GF
George Farmer Scotiabank Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
15
Avg Return
Past Year
Past Year
19%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
66.7%
Neutral
27.8%
Negative
5.6%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Sector Outperform
Maintained
| $10 |
609%
upside
| 1 | -11% |
0
%
| 6 Aug ‘25 5 months ago |
|
|
|
Sector Outperform
Maintained
| $133 |
100%
upside
| 2 | +9.7% |
0
%
| 31 Jul ‘25 5 months ago |
|
|
|
Sector Perform
Downgraded
| $9.20 |
6%
upside
| 2 | +28% |
0
%
| 8 Jul ‘25 6 months ago |
|
|
|
Sector Underperform
Downgraded
| $0.6000 |
60%
downside
| 2 | -20% |
0
%
| 1 Jul ‘25 6 months ago |
|
|
|
Sector Outperform
Maintained
| $47 |
113%
upside
| 1 | +102% |
0
%
| 13 Jun ‘25 7 months ago |
|
|
|
Sector Perform
Maintained
| $17 |
20%
downside
| 1 | – |
–
| 6 May ‘25 8 months ago |
|
|
|
Sector Outperform
Initiated
| $12 |
108%
upside
| 1 | +39% |
0
%
| 16 Apr ‘25 8 months ago |
|
|
|
Sector Perform
Downgraded
| $9 |
208%
upside
| 2 | -35% |
0
%
| 10 Apr ‘25 9 months ago |
|
|
|
Sector Outperform
Maintained
| $1.40 | – | 1 | -77% |
0
%
| 21 Mar ‘25 9 months ago |
|
|
|
Sector Perform
Maintained
| $41 |
192%
upside
| 1 | – |
–
| 28 Feb ‘25 10 months ago |
|
|
|
Sector Outperform
Maintained
| $52 |
45%
upside
| 1 | +82% |
0
%
| 27 Feb ‘25 10 months ago |
|
|
|
Sector Perform
Maintained
| $80 |
34%
upside
| 1 | – |
–
| 20 Feb ‘25 10 months ago |
|
|
|
Sector Outperform
Maintained
| $224 |
19%
upside
| 1 | +41% |
0
%
| 13 Feb ‘25 11 months ago |
|
|
|
Sector Outperform
Initiated
| $102 |
219%
upside
| 1 | +8.8% |
0
%
| 13 Feb ‘25 11 months ago |
|